...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Veru's stock nearly triples after oral COVID-19 treatment leads to 'statistically meaningful' reduction in deaths.

Wow that's interesting narmac. VERU has 80.05 mil shares outstanding and there was just over 350 mil shares traded today...4.3X's turnover in one day. That happens to be about US$ 1.15 billion or C$ 1.43 billion. With an estimate of 270 mil shrs outstanding an equal value for RVX would be about C$5.25 for COVID only.

That's a long way from the increases of both PFE and MRK when they came out with their COVID therapies. I wonder what the safety profile of this drug is compared to APB.

tada 

Share
New Message
Please login to post a reply